Residual Anti-Xa Activity After Last Treatment Dose of Enoxaparin
Stopped enrollment proved to be a challenge due to the changing of the guidelines for bridging off the new anticoagulants that are being prescribed
Conditions
- Anticoagulants and Bleeding Disorders
- Surgery
- Regional Anesthesia Morbidity
Interventions
- DRUG: Enoxaparin
- DRUG: Enoxaparin
Sponsor
Wake Forest University Health Sciences